# Stopping Pneumonia Antibiotherapy Regimen Early

> **NCT06291012** · PHASE4 · NOT_YET_RECRUITING · sponsor: **University Hospital, Montpellier** · enrollment: 1100 (estimated)

## Conditions studied

- Community-acquired Pneumonia
- Child, Only

## Interventions

- **DRUG:** Quick response: Amoxicillin for 3 days
- **DRUG:** Delayed response: Amoxicillin for 5 days
- **DRUG:** Quick response: Amoxicillin for 5 days
- **DRUG:** Delayed response: Amoxicillin for 7 days

## Key facts

- **NCT ID:** NCT06291012
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-09-01
- **Primary completion:** 2027-05-01
- **Final completion:** 2027-09-01
- **Target enrollment:** 1100 (ESTIMATED)
- **Last updated:** 2024-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06291012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06291012, "Stopping Pneumonia Antibiotherapy Regimen Early". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06291012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*